Company Overview
About Tempus
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder of Groupon) and headquartered in Chicago, Illinois, Tempus built the world's largest library of clinical and molecular data and applies AI to help physicians make more personalized, data-driven treatment decisions. The company's core offerings include genomic profiling (sequencing tumor DNA to identify mutations and actionable targets), algorithmic diagnostic tests (AI-driven companion diagnostics for cancer treatment selection), clinical trial matching (connecting eligible patients to appropriate studies), and data licensing to pharmaceutical and biotech partners for drug discovery and clinical development.
Business Model & Competitive Advantage
Tempus went public on Nasdaq in June 2024 under the ticker symbol TEM, making its capital markets debut as one of the most anticipated healthcare AI IPOs of the year. In full-year 2025, Tempus reported revenue of $1.27B, an 83% increase from $693M in 2024, and achieved a record total contract value exceeding $1.1 billion. The company's market capitalization exceeds $14B, and Tempus stock rose 87% in 2025. Tempus provides 2026 revenue guidance of approximately $1.59B, representing ~25% growth. The company's genomics segment (lab testing revenue) and data and services segment (AI-powered analytics and pharma partnerships) both contribute to the top line, with the data segment expanding rapidly as pharmaceutical companies license Tempus's multimodal dataset for drug development applications.
Competitive Landscape 2025–2026
Tempus's competitive moat rests on the scale and quality of its proprietary dataset — covering millions of de-identified patient records with linked clinical, genomic, imaging, and outcomes data. This dataset, continuously enriched through clinical partnerships with health systems nationwide, underpins AI model training that competitors cannot easily replicate. Tempus competes with Foundation Medicine (Roche), Guardant Health, and NeoGenomics in genomic profiling, and with Flatiron Health (Roche) in real-world data for pharma, but its integrated AI platform spanning multiple disease areas differentiates its offering.
Key Differentiators
Market Leader
Tempus is recognized as a market leader in the Life Sciences & BioTech sector, demonstrating strong industry presence and customer trust.
Enterprise Scale
With $1.27B in revenue, Tempus operates at enterprise scale with proven market validation.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Schrödinger
Schrödinger was founded in 1990 by Richard Friesner and David Pearlman in New York City, building physics-based computational methods for molecular simulation. For over 30 years the company has develo
Saama Analytics
Saama Analytics is the leading AI-driven clinical analytics and data management platform for the life sciences industry, positioning itself as the "#1 in AI Clinical Analytics" based on customer adopt
ConcertAI
ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates mult
DNAnexus
DNAnexus is the category-defining cloud platform for precision health data management, analysis, and collaboration. Founded in 2009 and headquartered in Mountain View, California, DNAnexus provides a
Karius
Karius is a Redwood City, CA-based life sciences company founded in 2014 that developed the Karius Test — a single blood draw that uses next-generation sequencing and AI to detect over 1,000 pathogens
Emulate
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m
Compare Tempus with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Tempus? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Tempus Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Tempus vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →